Skip to content


Akinbami, L. J. et al. (2011). Attention deficit hyperactivity disorder among children aged 5-17 years in the United States, 1998-2009. NCHS Data Brief. No. 70

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington: American Psychiatric Association, 2000.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA: American Psychiatric Association, 2013.

Arnold, G.L., et al. (2003). Plasma amino acids profiles in children with autism: potential risk of nutritional deficiencies. Journal of autism and developmental disorders. 33(4): p. 449-454.

Baker, M.G., Graham L. (2004). The journey: Parkinson’s disease. BMJ. 329 (7466): 611-614.

Bronte-Stewart, H.M., Minn, A. Y., et al. (2002). Postural instability in idiopathic Parkinson’s disease: the role of medication and unilateral pallidotomy. Guarantors of Brain. 125:2100-2114.

Cakit, B. D. (2007). The effects of incremental speed-dependent treadmill training on postural instability and fear of falling in Parkinson’s disease. Clinical Rehabilitation. 21:698-705

Christensen, D.L., et al. (2016). Prevalence and Characteristics of Autism Spectrum Disorder Among 4-Year-Old Children in the Autism and Developmental Disabilities Monitoring Network. Journal of Developmental & Behavioral Pediatrics. 37(1): p. 1-8.

de Lau, L.M. and M.M. Breteler (2006). Epidemiology of Parkinson’s disease. The Lancet Neurology. 5(6): p. 525-535.

Datamonitor ASD Epidemiology 2011, Child and Adolescent Psychiatric Clinics 2003, Booz & Company.

Dorsey, E.R. et al. (2007). Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology.

Edwards, L.L., et al. (1991). Gastrointestinal symptoms in Parkinson’s disease. Movement Disorders. 6(2): 151-156.

Evans, C., et al. (2008). Altered amino acid excretion in children with autism. Nutritional neuroscience. 11(1): p. 9-17.

Fafournoux, P., A. Bruhat, and C. Jousse (2000). Amino acid regulation of gene expression. Biochem J. 351(Pt 1): p. 1-12.

Global Industry Analysts. ADHD therapeutics – a global strategic business report. 2010.

Heetun, Z. Quigley, E. (2012). Gastroparesis and Parkinson’s disease: a systematic review. Parkinsonism and Related Disorders. 18: 443-440.

Krasner, N., et al. (1976). Alcohol and absorption from the small intestine. 1. Impairment of absorption from the small intestine in alcoholics. Gut. 17(4): p. 245-248.

Lo Bianco, C., Schneider, B.L., et al. (2004). Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an SYMBOL-synuclein rat model of Parkinson’s disease. Proceedings of the National Academy of Sciences. Vol. 101(50): 17510-17515.

Mezey, E., et al. (1970). Pancreatic function and intestinal absorption in chronic alcoholism. Gastroenterology. 59: p. 657-664.

National Institute for Mental Health (2012). ADHD.

National Parkinson Foundation (2013). How is PD treated?

Parkinson’s Disease Foundation (2016).

Perrotti, L., et al. (2008). Distinct patterns of ΔFosB induction in brain by drugs of abuse. Synapse. 62(5): p. 358-369.

Pfeiffer, R. (2007). Gastrointestinal and urinary function in PD. Parkinson’s Disease Foundation: Understanding Parkinson’s.

Pfeiffer, R. (2010). Gastrointestinal urological, and sexual dysfunction in Parkinson’s disease. Movement Disorders. Vol. 25: S94-S97

Regier, D.A., et al. (1993). The de facto US mental and addictive disorders service system: Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and services. Archives of general psychiatry. 50(2): p. 85-94.

Simonoff, E. et al. (2008). Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. Journal of American Academy of Child Adolescent Psychiatry. 47(8) 921-929.

Thomas, R., Sanders, S., Doust, J., Beller, E., & Glasziou, P. (2015). Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics, 135(4), 994-1001.

Visser, S.N., et al. (2014). Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003–2011. Journal of the American Academy of Child & Adolescent Psychiatry. 53(1): p. 34-46. e2. 

Wilens, T. et al. (2002). Attention deficit/hyperactivity disorder across the lifespan. Annual Review of Medicine. 53: 113-131

Wood, B.H., Bilclough, J.A., Bowron, A., Walker, R.W. (2002). Incidence and prediction of falls in Parkinson’s disease: a prospective multidisciplinary study. Journal of Neurology and Neurosurgery Psychiatry. 72: 721-725

Zhang, Y., et al. (2007). Differential effects of phenylalanine on Rac1, Cdc42, and RhoA expression and activity in cultured cortical neurons. Pediatric research. 62(1): p. 8-13.